The gastrointestinal bleeding treatment devices market size has grown strongly in recent years. It will grow from $0.92 billion in 2025 to $1 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing incidence of gastrointestinal disorders, rising prevalence of peptic ulcer disease, expansion of endoscopic diagnostic procedures, growing hospital-based gi interventions, availability of advanced endoscopy equipment.
The gastrointestinal bleeding treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of next-generation endoscopic devices, rising demand for outpatient gi procedures, growing focus on early bleeding detection, expansion of ambulatory surgical centers, increasing investments in advanced gi care technologies. Major trends in the forecast period include increasing adoption of advanced endoscopic hemostasis devices, rising use of minimally invasive gi bleeding treatments, growing demand for precision thermal ablation tools, expansion of mechanical hemostatic solutions, enhanced focus on rapid bleeding control technologies.
The rising prevalence of gastrointestinal disorders is anticipated to enhance the market's attractiveness. Gastrointestinal diseases may arise from factors such as a low-fiber diet, stress, insufficient water intake, high consumption of dairy products, a sedentary lifestyle, aging, and genetic predispositions. For example, in October 2024, the National Library of Medicine, a US-based national library, reported that in 2023, there were 825 cases per 100,000 Canadians diagnosed with inflammatory bowel disease (IBD), affecting over 320,000 individuals. Projections suggest that this number could increase to 1.1% of the population, approximately 470,000 Canadians, by 2035. Thus, the growing prevalence of disorders related to the gastrointestinal tract is propelling market growth.
Leading companies in the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray is a hemostatic powder designed to manage and control active bleeding in the GI tract. For instance, in January 2024, AIG Hospitals, an India-based medical institution, introduced Hemospray, marking a significant advancement in controlling GI bleeding. This hemostatic agent is specifically designed for use in endoscopic procedures to manage acute gastrointestinal (GI) bleeding. Hemospray is recognized for its ease of use, safety profile, and effectiveness in controlling a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.
In June 2023, Merck, a US-based global pharmaceutical company, acquired Prometheus Biosciences, Inc. for $10.8 billion. This acquisition greatly strengthens Merck's position in the immunology sector, an area in which the company had previously been less active. Prometheus Biosciences, Inc. is a US-based biotechnology firm that specializes in the discovery, development, and commercialization of innovative precision therapies and diagnostics for patients with gastrointestinal (GI) and immune-mediated diseases.
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC.
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal bleeding treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the gastrointestinal bleeding treatment devices market by increasing costs of imported endoscopic components, thermal generators, imaging accessories, and precision instruments. Hospitals and ambulatory centers in North America and Europe are most affected due to dependence on imported endoscopy systems, while Asia-Pacific faces higher export-related costs. These tariffs are increasing device procurement expenses and affecting upgrade cycles. However, they are also encouraging localized device assembly, regional manufacturing partnerships, and development of cost-efficient hemostatic technologies.
The gastrointestinal bleeding treatment devices market research report is one of a series of new reports that provides gastrointestinal bleeding treatment devices market statistics, including gastrointestinal bleeding treatment devices industry global market size, regional shares, competitors with a gastrointestinal bleeding treatment devices market share, detailed gastrointestinal bleeding treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal bleeding treatment devices industry. This gastrointestinal bleeding treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gastrointestinal (GI) bleeding serves as a symptom of an underlying illness where the gastrointestinal system experiences bleeding. The bleeding can manifest in various parts of the gastrointestinal tract, encompassing the large intestine, anus, esophagus, small intestine, rectum, and stomach.
In the gastrointestinal bleeding treatment devices market, the primary types of products include endoscopic mechanical devices, endoscopic thermal devices, and others. Endoscopic mechanical devices play a crucial role in managing GI arterial bleeding and comprise hemostatic clips, also known as through-the-scope (TTS) clips, endoscopic detachable snare ligation (EDSL) devices, endoscopic suturing, and over-the-scope clips (OTSC). These devices are subject to review for their technological applications and clinical utility. The segmentation of the gastrointestinal bleeding treatment devices market includes divisions based on the GI tract, distinguishing between the lower GI tract and upper GI tract. Additionally, these devices find application in various healthcare settings, such as hospitals or clinics, ambulatory surgical centers, and other medical facilities.
The gastrointestinal bleeding treatment devices market consists of sales of thermal therapy, multipolar electrocoagulation probe, heater probe, hemostatic foreceps, and argon plasma coagulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The gastrointestinal bleeding treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of next-generation endoscopic devices, rising demand for outpatient gi procedures, growing focus on early bleeding detection, expansion of ambulatory surgical centers, increasing investments in advanced gi care technologies. Major trends in the forecast period include increasing adoption of advanced endoscopic hemostasis devices, rising use of minimally invasive gi bleeding treatments, growing demand for precision thermal ablation tools, expansion of mechanical hemostatic solutions, enhanced focus on rapid bleeding control technologies.
The rising prevalence of gastrointestinal disorders is anticipated to enhance the market's attractiveness. Gastrointestinal diseases may arise from factors such as a low-fiber diet, stress, insufficient water intake, high consumption of dairy products, a sedentary lifestyle, aging, and genetic predispositions. For example, in October 2024, the National Library of Medicine, a US-based national library, reported that in 2023, there were 825 cases per 100,000 Canadians diagnosed with inflammatory bowel disease (IBD), affecting over 320,000 individuals. Projections suggest that this number could increase to 1.1% of the population, approximately 470,000 Canadians, by 2035. Thus, the growing prevalence of disorders related to the gastrointestinal tract is propelling market growth.
Leading companies in the gastrointestinal bleeding treatment devices market are concentrating on developing advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the gastrointestinal (GI) tract. Hemospray is a hemostatic powder designed to manage and control active bleeding in the GI tract. For instance, in January 2024, AIG Hospitals, an India-based medical institution, introduced Hemospray, marking a significant advancement in controlling GI bleeding. This hemostatic agent is specifically designed for use in endoscopic procedures to manage acute gastrointestinal (GI) bleeding. Hemospray is recognized for its ease of use, safety profile, and effectiveness in controlling a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.
In June 2023, Merck, a US-based global pharmaceutical company, acquired Prometheus Biosciences, Inc. for $10.8 billion. This acquisition greatly strengthens Merck's position in the immunology sector, an area in which the company had previously been less active. Prometheus Biosciences, Inc. is a US-based biotechnology firm that specializes in the discovery, development, and commercialization of innovative precision therapies and diagnostics for patients with gastrointestinal (GI) and immune-mediated diseases.
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC.
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal bleeding treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the gastrointestinal bleeding treatment devices market by increasing costs of imported endoscopic components, thermal generators, imaging accessories, and precision instruments. Hospitals and ambulatory centers in North America and Europe are most affected due to dependence on imported endoscopy systems, while Asia-Pacific faces higher export-related costs. These tariffs are increasing device procurement expenses and affecting upgrade cycles. However, they are also encouraging localized device assembly, regional manufacturing partnerships, and development of cost-efficient hemostatic technologies.
The gastrointestinal bleeding treatment devices market research report is one of a series of new reports that provides gastrointestinal bleeding treatment devices market statistics, including gastrointestinal bleeding treatment devices industry global market size, regional shares, competitors with a gastrointestinal bleeding treatment devices market share, detailed gastrointestinal bleeding treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal bleeding treatment devices industry. This gastrointestinal bleeding treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Gastrointestinal (GI) bleeding serves as a symptom of an underlying illness where the gastrointestinal system experiences bleeding. The bleeding can manifest in various parts of the gastrointestinal tract, encompassing the large intestine, anus, esophagus, small intestine, rectum, and stomach.
In the gastrointestinal bleeding treatment devices market, the primary types of products include endoscopic mechanical devices, endoscopic thermal devices, and others. Endoscopic mechanical devices play a crucial role in managing GI arterial bleeding and comprise hemostatic clips, also known as through-the-scope (TTS) clips, endoscopic detachable snare ligation (EDSL) devices, endoscopic suturing, and over-the-scope clips (OTSC). These devices are subject to review for their technological applications and clinical utility. The segmentation of the gastrointestinal bleeding treatment devices market includes divisions based on the GI tract, distinguishing between the lower GI tract and upper GI tract. Additionally, these devices find application in various healthcare settings, such as hospitals or clinics, ambulatory surgical centers, and other medical facilities.
The gastrointestinal bleeding treatment devices market consists of sales of thermal therapy, multipolar electrocoagulation probe, heater probe, hemostatic foreceps, and argon plasma coagulation. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Gastrointestinal Bleeding Treatment Devices Market Characteristics
3. Gastrointestinal Bleeding Treatment Devices Market Supply Chain Analysis
4. Global Gastrointestinal Bleeding Treatment Devices Market Trends and Strategies
5. Gastrointestinal Bleeding Treatment Devices Market Analysis of End Use Industries
7. Global Gastrointestinal Bleeding Treatment Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Gastrointestinal Bleeding Treatment Devices Total Addressable Market (TAM) Analysis for the Market
9. Gastrointestinal Bleeding Treatment Devices Market Segmentation
10. Gastrointestinal Bleeding Treatment Devices Market Regional and Country Analysis
11. Asia-Pacific Gastrointestinal Bleeding Treatment Devices Market
12. China Gastrointestinal Bleeding Treatment Devices Market
13. India Gastrointestinal Bleeding Treatment Devices Market
14. Japan Gastrointestinal Bleeding Treatment Devices Market
15. Australia Gastrointestinal Bleeding Treatment Devices Market
16. Indonesia Gastrointestinal Bleeding Treatment Devices Market
17. South Korea Gastrointestinal Bleeding Treatment Devices Market
18. Taiwan Gastrointestinal Bleeding Treatment Devices Market
19. South East Asia Gastrointestinal Bleeding Treatment Devices Market
20. Western Europe Gastrointestinal Bleeding Treatment Devices Market
21. UK Gastrointestinal Bleeding Treatment Devices Market
22. Germany Gastrointestinal Bleeding Treatment Devices Market
23. France Gastrointestinal Bleeding Treatment Devices Market
24. Italy Gastrointestinal Bleeding Treatment Devices Market
25. Spain Gastrointestinal Bleeding Treatment Devices Market
26. Eastern Europe Gastrointestinal Bleeding Treatment Devices Market
27. Russia Gastrointestinal Bleeding Treatment Devices Market
28. North America Gastrointestinal Bleeding Treatment Devices Market
29. USA Gastrointestinal Bleeding Treatment Devices Market
30. Canada Gastrointestinal Bleeding Treatment Devices Market
31. South America Gastrointestinal Bleeding Treatment Devices Market
32. Brazil Gastrointestinal Bleeding Treatment Devices Market
33. Middle East Gastrointestinal Bleeding Treatment Devices Market
34. Africa Gastrointestinal Bleeding Treatment Devices Market
36. Gastrointestinal Bleeding Treatment Devices Market Competitive Landscape and Company Profiles
37. Gastrointestinal Bleeding Treatment Devices Market Other Major and Innovative Companies
40. Gastrointestinal Bleeding Treatment Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Gastrointestinal Bleeding Treatment Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses gastrointestinal bleeding treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for gastrointestinal bleeding treatment devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal bleeding treatment devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Endoscopic Thermal Hemostasis Devices; Mechanical Hemostasis Devices; Injection-Based Hemostasis Devices; Topical Hemostatic Agents & Powders; Combination Or Multimodal Hemostasis Devices2) By GI Tract Division: Upper GI Tract; Lower GI Tract
3) By End User: Hospitals Or Clinics; Ambulatory Surgical Centers; Other End-users
Subsegments:
1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices; Argon Plasma Coagulation (APC) Devices; Radiofrequency Ablation (RFA) Devices; Laser Coagulation Devices; Heater Probe Devices2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips); Endoscopic Band Ligation Devices; Endoscopic Suturing Devices; Compression And Tamponade Devices
3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems; Sclerosant Injection Devices; Cyanoacrylate Glue Injection Devices; Saline And Combination Injection Systems
4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays; Absorbable Hemostatic Agents; Fibrin-Based Sealants; Collagen-Based Hemostatic Agents
5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems; Injection And Mechanical Combination Systems; Integrated Multimodal Endoscopic Hemostasis Platforms
Companies Mentioned: CONMED Corporation; Boston Scientific Corporation; Ovesco Endoscopy AG; Olympus Corporation; Cook Medical; Erbe Elektromedizin GmbH; Steris plc; Medtronic plc; Johnson & Johnson; Abbott Laboratories; Fujifilm Holdings Corporation; Pentax Medical; Merit Medical Systems; Teleflex Incorporated; AngioDynamics; BTG International Ltd.; Smiths Medical; Terumo Corporation; Nipro Corporation; C. R. Bard Inc.; EndoChoice Holdings Inc.; GI Supply Inc.; Hemostasis LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Gastrointestinal Bleeding Treatment Devices market report include:- CONMED Corporation
- Boston Scientific Corporation
- Ovesco Endoscopy AG
- Olympus Corporation
- Cook Medical
- Erbe Elektromedizin GmbH
- Steris plc
- Medtronic plc
- Johnson & Johnson
- Abbott Laboratories
- Fujifilm Holdings Corporation
- Pentax Medical
- Merit Medical Systems
- Teleflex Incorporated
- AngioDynamics
- BTG International Ltd.
- Smiths Medical
- Terumo Corporation
- Nipro Corporation
- C. R. Bard Inc.
- EndoChoice Holdings Inc.
- GI Supply Inc.
- Hemostasis LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1 Billion |
| Forecasted Market Value ( USD | $ 1.39 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
